GO:0036430 CMP kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036430 (CMP kinase activity) catalyzes the reversible phosphorylation of CMP to CDP using ATP, a critical step in pyrimidine nucleotide metabolism.
• The reaction is performed by UMP-CMP kinases (CMPK1 and CMPK2) in humans, which also phosphorylate UMP and dCMP, linking them to broader nucleotide salvage and antiviral responses.
• CMPK1 is cytosolic and provides nucleotides for DNA/RNA synthesis, while CMPK2 is mitochondrial and plays a key role in type I interferon signaling and ZIKV restriction.
• Structural studies reveal substrate-induced conformational changes that govern catalysis and specificity, and bacterial homologs show conserved NMP kinase folds.
• Dysregulation of CMP kinase activity is implicated in cancer chemoresistance (e.g., doxorubicin binding) and viral infections, making it a target for therapeutic intervention.
• CRISPR-based knockout, point mutation, and overexpression models enable precise dissection of CMPK1/2 functions in nucleotide metabolism and innate immunity.
Description
CMP kinase activity (GO:0036430) is a molecular function defined by the catalysis of the reaction ATP + CMP = ADP + CDP. This phosphorylation event is essential for the salvage and interconversion of pyrimidine nucleotides, providing precursors for RNA and DNA synthesis. In humans, this activity is carried out by UMP-CMP kinases, primarily CMPK1 (cytosolic) and CMPK2 (mitochondrial), which exhibit broad substrate specificity toward UMP, CMP, and dCMP. The importance of CMP kinase activity extends beyond basic metabolism: it is involved in antiviral defense, mitochondrial function, and cellular responses to chemotherapeutic agents. Researchers study this term to understand nucleotide homeostasis, innate immunity, and potential drug targets.
CMP kinase activity At A Glance
| GO ID | GO:0036430 |
|---|---|
| GO term | CMP kinase activity |
| Ontology | molecular_function |
| Synonym | None |
| Major function | Phosphorylation of CMP to CDP using ATP |
| Reaction | ATP + CMP = ADP + CDP |
| Enzyme class | Nucleoside monophosphate kinase (NMP kinase) |
| Human genes | CMPK1, CMPK2 |
| Subcellular localization | Cytosol (CMPK1), mitochondria (CMPK2) |
What Is GO:0036430?
CMP kinase activity (GO:0036430) is the catalysis of the chemical reaction ATP + CMP = ADP + CDP. In other words, it transfers a phosphate group from ATP to CMP, producing CDP and ADP. This activity is a type of nucleoside monophosphate kinase and is essential for converting CMP into CDP, a precursor for CDP-choline and DNA/RNA building blocks.
Why Is CMP kinase activity Important in Cell Biology?
CMP kinase activity is a cornerstone of pyrimidine nucleotide metabolism, directly impacting DNA replication, RNA transcription, and phospholipid synthesis. Its role in activating antiviral signaling through CMPK2 highlights its importance in innate immunity. Moreover, CMPK1 is a target of doxorubicin, linking it to cancer chemoresistance. Understanding this activity is therefore critical for developing therapies against viral infections, cancer, and mitochondrial disorders.
• Provides CDP for DNA and RNA synthesis and for CDP-choline in phospholipid metabolism.
• CMPK2 is a mitochondrial protein that enhances type I interferon signaling and restricts ZIKV replication.
• CMPK1 binds doxorubicin, suggesting a role in drug response and chemoresistance.
• Palmitoylation of CMPK2 by ZDHHC20 promotes antiviral innate immunity.
• Bacterial CMP kinases are structurally conserved, offering insights into antibiotic targets.
• Engineered CMP kinases enable efficient enzymatic synthesis of cytidine triphosphate for biotechnological applications.
• Substrate-induced conformational changes regulate catalytic efficiency and specificity.
• Dysregulation may contribute to mitochondrial dysfunction and metabolic disorders.
Molecular Mechanism of CMP kinase activity
Substrate Binding and Conformational Change
In simple terms: The enzyme changes shape when it grabs CMP and ATP to perform the reaction.
Human UMP/CMP kinase undergoes significant substrate-induced conformational changes. Structural studies show that binding of CMP and ATP induces a closure of the active site, aligning catalytic residues for phosphoryl transfer. This induced-fit mechanism ensures high specificity for pyrimidine nucleotides over purines.
Catalytic Mechanism and Phosphoryl Transfer
In simple terms: The enzyme transfers a phosphate from ATP to CMP, making CDP.
The catalytic mechanism involves a direct in-line transfer of the gamma-phosphate from ATP to the 5'-hydroxyl of CMP. Key residues in the P-loop and catalytic loop stabilize the transition state. The reaction is reversible, but under physiological conditions, it favors CDP formation.
Substrate Specificity and Isoforms
In simple terms: Different versions of the enzyme prefer different substrates.
CMPK1 phosphorylates UMP, CMP, and dCMP, while CMPK2 is localized to mitochondria and also accepts these substrates. The broad specificity allows these enzymes to participate in both de novo and salvage pathways.
Regulation by Post-translational Modifications
In simple terms: Chemical tags on the enzyme can turn its activity up or down.
CMPK2 is palmitoylated by ZDHHC20, which promotes its antiviral function and enhances type I interferon signaling. This modification represents a layer of regulation that links lipid metabolism to innate immunity.
Key Genes Involved in GO:0036430 CMP kinase activity
The following genes encode proteins with CMP kinase activity or directly regulate it.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CMPK1 | Cytosolic UMP-CMP kinase; phosphorylates CMP, UMP, dCMP | Nucleotide salvage, doxorubicin binding, cancer chemoresistance |
| CMPK2 | Mitochondrial UMP-CMP kinase; involved in antiviral signaling | ZIKV restriction, type I IFN activation, palmitoylation |
| ZDHHC20 | Palmitoyltransferase that modifies CMPK2 | Regulates antiviral innate immunity |
| ATP | Phosphate donor in the reaction | Cofactor for CMP kinase activity |
| CMP | Substrate; phosphorylated to CDP | Central pyrimidine nucleotide |
| UMP | Alternative substrate for UMP-CMP kinases | Pyrimidine salvage |
| dCMP | Deoxyribonucleotide substrate | DNA synthesis precursor |
| CDP | Product; precursor for DNA/RNA and phospholipids | Metabolic intermediate |
| E. coli CMP kinase | Bacterial homolog; structural model | Antibiotic target research |
| Engineered CMP kinase | Halotolerant variant for CTP synthesis | Biotechnological applications |
| IFN-I | Type I interferon; downstream of CMPK2 | Antiviral response |
| ZIKV | Zika virus; restricted by CMPK2 | Viral infection model |
| Doxorubicin | Chemotherapeutic that binds CMPK1 | Cancer drug response |
| Palmitic acid | Induces CMPK2 palmitoylation | Metabolic regulation of immunity |
How Is CMP kinase activity Regulated?
CMP kinase activity is regulated at multiple levels. CMPK2 is transcriptionally induced by interferons and post-translationally modified by palmitoylation, which enhances its antiviral function. CMPK1 activity can be influenced by substrate availability and potentially by phosphorylation, though specific regulatory pathways remain to be fully elucidated. The enzyme's conformational changes upon substrate binding also serve as an intrinsic regulatory mechanism.
CMP kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CMPK2 | Zika virus infection | CMPK2 knockout cells + ZIKV infection |
| CMPK1 | Doxorubicin resistance in cancer | CMPK1 overexpression in cancer cell lines |
| CMPK2 | Mitochondrial dysfunction | CMPK2 knockout mitochondria |
| ZDHHC20 | Antiviral innate immunity | ZDHHC20 knockout + palmitic acid treatment |
Viral Infections
CMPK2 restricts ZIKV replication by activating type I interferon signaling, and its palmitoylation by ZDHHC20 is essential for this antiviral response. This positions CMPK2 as a key player in innate immunity against flaviviruses.
Cancer Chemoresistance
CMPK1 was identified as a doxorubicin-binding protein, suggesting it may modulate drug sensitivity in cancer cells. Altered CMP kinase activity could affect nucleotide pools and influence chemotherapy outcomes.
Mitochondrial Dysfunction
CMPK2 is localized to mitochondria, where it contributes to mitochondrial nucleotide metabolism. Dysregulation may impair mitochondrial function and contribute to metabolic disorders.
From CMP kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CMPK1 loss affect nucleotide pools? | CMPK1 knockout cell line |
| Does CMPK2 point mutation abolish antiviral activity? | CMPK2 point-mutant knock-in |
| Can CMPK2 palmitoylation be tracked? | CMPK2 tagged knock-in (e.g., FLAG) |
| Does CMPK1 overexpression confer doxorubicin resistance? | CMPK1 overexpression stable line |
| What is the impact of CMPK2 on interferon signaling? | CMPK2 knockout + IFN reporter |
| Can engineered CMP kinase improve CTP synthesis? | Bacterial expression + enzyme assay |
How to Study the CMP kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Coupled kinase assay | ADP production or CDP formation | Enzyme kinetics |
| X-ray crystallography | 3D structure of enzyme-substrate complex | Conformational changes |
| CRISPR knockout screen | Gene essentiality or antiviral restriction | Identify CMPK2 pathway components |
| Protein microarray | Small molecule-protein interactions | Doxorubicin binding to CMPK1 |
| Western blot | Protein expression and palmitoylation | CMPK2 modification |
| qRT-PCR | mRNA levels of CMPK1/2 | Interferon stimulation |
| Enzymatic synthesis | CTP production | Biotechnological application |
Enzymatic Activity Assays
CMP kinase activity is typically measured using coupled spectrophotometric assays that monitor ADP production or CDP formation. These assays are essential for characterizing wild-type and mutant enzymes.
Structural Biology
X-ray crystallography and NMR have been used to solve structures of human UMP/CMP kinase in complex with substrates, revealing conformational changes. These methods guide inhibitor design.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes that modulate CMP kinase activity or its downstream effects, such as antiviral responses.
Proteomics and Interaction Studies
Protein microarrays and immunoprecipitation have identified CMPK1 as a doxorubicin-binding protein. Similar approaches can uncover new interaction partners.
How CRISPR Can Be Used to Study GO:0036430 CMP kinase activity
Knockout
CRISPR knockout of CMPK1 or CMPK2 enables researchers to study loss-of-function phenotypes, such as altered nucleotide pools, impaired antiviral responses, or mitochondrial dysfunction.
Point Mutation
Introducing point mutations in catalytic residues of CMPK1/2 can dissect the enzymatic contribution to cellular processes, separating kinase activity from scaffolding functions.
Knock-in
Tagged knock-in of CMPK2 (e.g., with FLAG or HA) allows tracking of localization, palmitoylation, and interaction partners in native contexts.
Overexpression
Overexpression of CMPK1 or CMPK2 can test gain-of-function effects, such as enhanced antiviral signaling or chemoresistance.
How EDITGENE Supports CMP kinase activity Research
Researchers studying CMP kinase activity-related genes often need to determine whether a candidate gene is causally involved in nucleotide metabolism, antiviral immunity, or drug response. EDITGENE provides custom CRISPR cell models to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for CMP kinase activity research.
Frequently Asked Questions About CMP kinase activity
What is CMP kinase activity?
CMP kinase activity (GO:0036430) is the catalysis of ATP + CMP = ADP + CDP, a key step in pyrimidine nucleotide metabolism.
What genes are involved in CMP kinase activity?
The main human genes are CMPK1 and CMPK2, which encode UMP-CMP kinases.
Where is CMP kinase activity located in the cell?
CMPK1 is cytosolic, while CMPK2 is mitochondrial.
What is the role of CMPK2 in antiviral immunity?
CMPK2 restricts ZIKV replication by activating type I interferon signaling, and its palmitoylation enhances this function.
How is CMP kinase activity regulated?
It is regulated by substrate availability, conformational changes, and post-translational modifications such as palmitoylation.
What diseases are associated with CMP kinase activity?
Viral infections, cancer chemoresistance, and mitochondrial dysfunction.
How can I study CMP kinase activity using CRISPR?
Knockout, point mutation, knock-in, and overexpression models can be generated to study its function.
What methods measure CMP kinase activity?
Coupled enzymatic assays, structural biology, and CRISPR screens.
Is CMP kinase activity a drug target?
Yes, CMPK1 binds doxorubicin, and CMPK2 is a target for antiviral strategies.
What is the reaction catalyzed by CMP kinase?
ATP + CMP = ADP + CDP.
Conclusion
CMP kinase activity (GO:0036430) is a fundamental enzymatic function in pyrimidine metabolism with expanding roles in antiviral immunity and cancer. The human enzymes CMPK1 and CMPK2 are attractive targets for therapeutic development and basic research. CRISPR-based models offer powerful tools to dissect their precise contributions to health and disease.
References
- 1. Pearman AT et al.. 2001. Characterization of human UMP-CMP kinase enzymatic activity and 5' untranslated region.. Life Sci 69(20):2361-70 PMID: 11681623
- 2. Zhu Y et al.. 2024. UMP-CMP kinase 2 inhibits ZIKV replication through activation of type I IFN signaling pathway.. J Med Virol 96(3):e29533 PMID: 38483048
- 3. Xu Y et al.. 2008. Human UMP-CMP kinase 2, a novel nucleoside monophosphate kinase localized in mitochondria.. J Biol Chem 283(3):1563-1571 PMID: 17999954
- 4. Wang Y et al.. 2026. Palmitic Acid Promotes Antiviral Innate Immunity via ZDHHC20-Mediated CMPK2 Palmitoylation.. Adv Sci (Weinh) 13(37):e75209 PMID: 42011944
- 5. Segura-Peña D et al.. 2004. Substrate-induced conformational changes in human UMP/CMP kinase.. J Biol Chem 279(32):33882-9 PMID: 15163660
- 6. Chen S et al.. 2017. Identification of Human UMP/CMP Kinase 1 as Doxorubicin Binding Target Using Protein Microarray.. SLAS Discov 22(8):1007-1015 PMID: 28459633
- 7. Bucurenci N et al.. 1996. CMP kinase from Escherichia coli is structurally related to other nucleoside monophosphate kinases.. J Biol Chem 271(5):2856-62 PMID: 8576266
- 8. Wen Q et al.. 2023. Computational aided design of a halotolerant CMP kinase for enzymatic synthesis of cytidine triphosphate.. Bioprocess Biosyst Eng 46(4):499-505 PMID: 36800017
